Clinical trial
Two Rizatriptan Prescribing Portions for Treatment of Migraine
NCT00397254 · Clinvest, Other · Completed
Key facts
| NCT number | NCT00397254 |
|---|---|
| Title | Two Rizatriptan Prescribing Portions for Treatment of Migraine |
| Official title | An Observer-Blind, Randomized, Parallel-Group Study to Compare the Efficacy of Two Rizatriptan Prescribing Portions for the Treatment of Migraine |
| Lead sponsor | Clinvest, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Drug |
| Interventions | rizatriptan |
| Enrollment | 197 |
| Start date | Dec 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Nov 9, 2006 |
| Last update posted | Jun 8, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: